Tuesday, February 25, 2014

AstraZeneca: FDA Approves Myalept for Leptin Deficiency Treatment

Research-based biopharmaceutical company AstraZeneca PLC said Tuesday the U.S. Food and Drug Administration approved orphan drug MYALEPT.



from WSJ.com: US Business http://ift.tt/1kb8ptp

via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)